Insider Cluster (7 insiders) ·Filed Mar 4, 2026

PEPG

PepGen Inc.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $45K total
Actionable Insight • Neutral

Monitor for additional insider selling in coming weeks — isolated small sales are routine, but a pattern could signal concern. The large grants suggest long-term retention incentives remain intact.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
PEPG ▼ -77.81% at T+60d
NEUTRAL call ✗ call lost -77.81% · α vs SPY -87.90% · entry $6.76 → $1.50
Entry anchored
Mar 3, 03:59 PM ET
via exchange tick
T+1d
-18.57%
call -18.57% · α -17.99%
$5.51
settled 7mo ago
T+5d
-6.95%
call -6.95% · α -5.62%
$6.29
settled 7mo ago
T+20d
-74.26%
call -74.26% · α -69.84%
$1.74
settled 6mo ago
T+60d
-77.81%
call -77.81% · α -87.90%
$1.50
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

PepGen insiders executed a mix of open-market sales and non-cash award grants. CEO and CFO sold a combined $44.7K in shares, while all five C-suite executives received stock awards totaling over 379K shares. The sales represent a small fraction of market cap and are likely part of pre-arranged plans, while the grants are routine compensation.

Key Financial Metrics

Direction
selling
Total Value
$44.7K
Insiders
7

Key Facts

  • CEO James McArthur sold 5,144 shares for $32,047; CFO Noel Donnelly sold 2,032 shares for $12,659 — total open-market sales: $44,706
  • All five C-suite executives received non-cash stock awards on March 1, 2026, totaling 379,355 shares with $0 transaction value
  • Total dollar value of open-market activity: $44,706, representing just 0.012% of $378M market cap
  • No board members or non-executive insiders involved; all transactions tied to executive compensation and planned sales

Financial Impact

$44,706 in net insider selling, offset by $0 in non-cash grants

insider ownershipshare count (dilutive impact from grants)

Risk Factors

  • Perception risk if media or retail investors misinterpret routine sales as negative signal
  • Future dilution from granted shares, though not immediate

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (7 trades, 7d window)cluster-PEPG-1772831553882
8 reports for PEPG
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+20▲ +31.95%Aug 6, 2026
Filters
Rows
Reports for PEPG — sortable, filterable
TypeNow
Aug 6, 2026
8w ago
8-K
BULLISH ★ 7/10
$2.41 $3.18▲ +31.95%▲ +31.35%$2.28 (−5.60%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 2/10
$1.51 $2.30▲ +52.32%▲ +50.43%$2.28 (+50.66%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 3/10
$1.51 $2.30▲ +52.32%▲ +50.43%$2.28 (+50.66%)
May 22, 2026
19w ago
EFFECT
BEARISH ★ 7/10
$1.51 $1.90▼ −25.83%▼ −27.24%$2.28 (−50.66%)
May 19, 2026
19w ago
S-3
BEARISH ★ 7/10
$1.38 $1.70▼ −23.19%▼ −22.20%$2.28 (−64.86%)
May 12, 2026
20w ago
8-K
NEUTRAL ★ 5/10
$1.78 $1.51▼ −15.17%▼ −14.56%$2.28 (+27.81%)
Mar 4, 2026
30w ago
8-K
MIXED ★ 6/10
$5.51 $1.73▼ −68.57%▼ −64.79%$2.28 (−58.67%)
Mar 4, 2026
30w ago
Insider Cluster
NEUTRAL ★ 3/10
$6.76 $1.74▼ −74.26%▼ −69.84%$2.28 (−66.35%)
Showing 8 of 8

US Market Status

Market Open — Closes in 2h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 6, 2026